Earnings per Share (EPS) (Basic) (Annual)

Earnings per Share (EPS) (Basic): A company's net earnings or losses attributable to common shareholders per basic share basis.

Syndax Pharmaceuticals, Inc. (SNDX) had Earnings per Share (EPS) (Basic) of $-3.29 for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$172.35M
Net Income	$-285.42M
Cost of Goods Sold	$6.97M
Gross Profit	$165.38M
Operating Expenses	$445.44M
Operating Income	$-273.08M
Non-Operating Income/Expense	$-12.34M
Pre-Tax Income	$-285.42M
Normalized Pre-Tax Income	$-285.42M
Income after Taxes	$-285.42M
Income from Continuous Operations	$-285.42M
Consolidated Net Income/Loss	$-285.42M
Normalized Income after Taxes	$-285.42M
EBIT	$-273.08M
EBITDA	$-283.60M
Weighted-Average Shares Outstanding (Basic)	86.63M
Weighted-Average Shares Outstanding (Diluted)	86.63M
Earnings per Share (EPS) (Basic)	$-3.29
Earnings per Share (EPS) (Diluted)	$-3.29
Balance Sheet Financials
Current Assets	$528.08M
Property, Plant, and Equipment	$0.18M
Long-Term Assets	$1.62M
Total Assets	$529.71M
Current Liabilities	$120.12M
Long-Term Debt	$343.91M
Long-Term Liabilities	$344.96M
Total Liabilities	$465.08M
Common Equity	$64.63M
Tangible Shareholders Equity	$64.63M
Shareholders Equity	$64.63M
Common Shares Outstanding	87.41M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-322.98M
Cash Flow from Investing Activities	$290.04M
Cash Flow from Financial Activities	$13.68M
Beginning Cash	$154.30M
End Cash	$135.03M
Increase/Decrease in Cash	$-19.27M
Stock-Based Compensation	$47.50M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	4.40
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.84
Debt to Equity Ratio	5.32
Gross Margin	95.96%
Operating Margin	-158.45%
EBIT Margin	-158.45%
EBITDA Margin	-164.55%
Pre-Tax Profit Margin	-165.60%
Profit Margin	-165.60%
Free Cash Flow	$-323.17M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.33
Inventory Turnover	0.21
Receiveable Turnover	2.53
Days Sales in Receivables	144.31
Return on Equity	-441.62%
Return on Tangible Equity	-441.62%
Return on Assets	-53.88%
Return on Investments	-69.86%
Book Value Per Share	$0.74
Free Cash Flow per Share	$-3.73
Operating Cash Flow per Share	$-3.73

Data from Zacks Investment Research, Inc.